Lenz Therapeutics, Inc. — Form D
Lenz Therapeutics, Inc. of DEL MAR, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-10. The offering totals $83.5M, of which $83.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-03-10
- Form: D
- Accession: 0001678518-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $83.5M
- Amount sold: $83.5M
- Investors: 27
- Date of first sale: 2023-03-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-475519
Issuer
- Name: Lenz Therapeutics, Inc.
- CIK: 0001678518
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 445 MARINE VIEW AVE., SUITE #320, DEL MAR, CA, 92014
- Phone: 619-890-5125
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| CHRIS DIMITROPOULOS | Director | SAN DIEGO, CA |
| Frederic Guerard | Director | Dedham, MA |
| Stefan Larson | Director | Del Mar, CA |
| James McCollum | Director | Del Mar, CA |
| Clare Ozawa | Director | South San Francisco, CA |
| Zach Scheiner | Director | Boston, MA |
| Evert Schimmelpennink | Director | Bryan, TX |
| Evert Schimmelpennink | Executive Officer | Bryan, TX |
| Mark Lester | Executive Officer | Tucson, AZ |
| James McCollum | Executive Officer | Del Mar, CA |
| Fred Guerard | Director | Del Mar, CA |
| Mark W Lester | Director | Wellesley, MA |
| Mark W Lester | Executive Officer | Wellesley, MA |
| Gerald W Horn | Director | Deerfield, IL |
| Gerald W Horn | Executive Officer | Deerfield, IL |
| James W McCollum | Director | Coronado, CA |
| James W McCollum | Executive Officer | Coronado, CA |
| GERALD HORN | Executive Officer | CORONADO, CA |
Other filings by this issuer (4)
More